Search for: "Gottlieb v Gottlieb" Results 101 - 120 of 416
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Nov 2019, 6:57 am by Florian Mueller
ZTEBram Nijhof (Counsel, Taylor Wessing)The proportionality requirement under the EU enforcement directiveMaurits Dolmans (Partner, Cleary Gottlieb Steen & Hamilton)The German patent reform debateModerator: Florian Mueller (Founder, FOSS Patents)Panelists: Messrs. [read post]
13 Oct 2019, 1:07 pm by Ron Friedmann
I hope we learn more here about how data can help avoid lawsuits or at least reduce the expense of dealing with them  Speakers:  James Lee, CEO/Co-Founder,  LegalMationPatrick V. [read post]
12 Jun 2019, 11:56 am by Jeff Margulies (US)
In a statement, FDA Commission Scott Gottlieb, M.D., stated: We’ve taken this position because we too have carefully reviewed the most current research on coffee and cancer and it does not support a cancer warning for coffee. [read post]
12 Jun 2019, 11:56 am by Jeff Margulies (US)
In a statement, FDA Commission Scott Gottlieb, M.D., stated: We’ve taken this position because we too have carefully reviewed the most current research on coffee and cancer and it does not support a cancer warning for coffee. [read post]
16 May 2019, 5:54 am
Posted by Jennifer Kennedy Park, Lev Dassin, and Georgia Stasinopoulos, Cleary Gottlieb Steen & Hamilton LLP, on Thursday, May 16, 2019 Editor's Note: Jennifer Kennedy Park and Lev Dassin are partners and Georgia V. [read post]
15 May 2019, 9:06 pm by Edward Hale
The agency, however, has reclassified FDA-Approved drugs that contain less than 0.1 percent CBD as Schedule V drugs—an apparent carve out for Epidolex. [read post]